Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-(3-(dimethylaminomethylideneamino)-2,4,6-triiodophenyl)propanoic Acid
2. Benzenepropanoic Acid, 3-(((dimethylamino)methylene)amino)-2,4,6-triiodo-
3. Bilimin
4. Biloptin
5. Calcium Iopodate
6. Calcium Ipodate
7. Iopodate
8. Iopodate, Calcium
9. Iopodate, Sodium
10. Ipodate
11. Ipodate, Calcium
12. Ipodate, Sodium
13. Sodium Iopodate
14. Sodium Ipodate
15. Solu Biloptin
16. Solu-biloptin
1. Sodium Iopodate
2. Sodium Ipodate
3. 1221-56-3
4. Bilivist
5. Biloptin
6. Oragrafin Sodium
7. Ipodate Sodium Salt
8. Biloptinon
9. Sodium 3-(3-{[(dimethylamino)methylene]amino}-2,4,6-triiodophenyl)propanoate
10. Nsc-106962
11. Sodium Iopodate (jan)
12. Ipodate Sodium [usan]
13. Iopodate Sodium
14. Sodium Triiodohydrocinnamate
15. Sodium Iopodate [inn]
16. Sodium Iopodate [jan]
17. F316llw9ww
18. Zk 15
19. Sh 514
20. Sodium 3-(((dimethylamino)methylene)amino)-2,4,6-triiodohydrocinnamate
21. Benzenepropanoic Acid, 3-(((dimethylamino)methylene)amino)-2,4,6-triiodo-, Sodium Salt
22. Ipodate Sodium (usan)
23. Oragrafin-sodium
24. Orgrafin
25. Iodopato Sodico
26. Natrii Iopodas
27. Benzenepropanoic Acid, 3-[[(dimethylamino)methylene]amino]-2,4,6-triiodo-, Sodium Salt
28. Iopodate De Sodium
29. Natrii Iopodas [inn-latin]
30. Iodopato Sodico [inn-spanish]
31. Iopodate De Sodium [inn-french]
32. Ncgc00181092-01
33. Einecs 214-945-3
34. Unii-f316llw9ww
35. Ipodate Sodium [usan:usp]
36. Sq-15761
37. Oragrafin Sodium (tn)
38. 3-((dimethylaminomethylene)amino)-2,4,6-triiodohydrocinnamic Acid Sodium Salt
39. Beta-(2,4,6-trijod-3-dimethylaminomethylenamino-phenyl)-propionsaeure [german]
40. Benzenepropanoic Acid, 3-((dimethylaminomethylene)amino)-2,4,6-triiodo-, Sodium Salt
41. Dsstox_cid_28246
42. Dsstox_rid_82748
43. Sodium Salt Of 3-(3-dimethylaminomethyleneamino-2,4,6-triiodophenyl)propionic Acid
44. Dsstox_gsid_48271
45. Ipodatesodium(200mg)
46. Ipodate Sodium [vandf]
47. Chebi:5953
48. Chembl1201033
49. Chembl3184539
50. Dtxsid9048271
51. Sodium Iopodate [mart.]
52. Iopodate Sodium [who-dd]
53. Ipodate Sodium Salt [mi]
54. Baa22156
55. Tox21_112708
56. Beta-(2,4,6-trijod-3-dimethylaminomethylenamino-phenyl)-propionsaeure
57. Ipodate Sodium [orange Book]
58. Ipodate Sodium [usp Impurity]
59. Akos005111003
60. Sodium;3-[3-(dimethylaminomethylideneamino)-2,4,6-triiodophenyl]propanoate
61. Hydrocinnamic Acid, 3-((dimethylaminomethylene)amino)-2,4,6-triiodo-, Sodium Salt
62. Cas-1221-56-3
63. Ft-0682674
64. D01015
65. Q15409424
Molecular Weight | 619.94 g/mol |
---|---|
Molecular Formula | C12H12I3N2NaO2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 619.7931 g/mol |
Monoisotopic Mass | 619.7931 g/mol |
Topological Polar Surface Area | 55.7 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 345 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AC - Watersoluble, hepatotropic x-ray contrast media
V08AC08 - Sodium iopodate
ABOUT THIS PAGE
37
PharmaCompass offers a list of Ipodate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ipodate manufacturer or Ipodate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ipodate manufacturer or Ipodate supplier.
PharmaCompass also assists you with knowing the Ipodate API Price utilized in the formulation of products. Ipodate API Price is not always fixed or binding as the Ipodate Price is obtained through a variety of data sources. The Ipodate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Solu Biloptin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Solu Biloptin, including repackagers and relabelers. The FDA regulates Solu Biloptin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Solu Biloptin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Solu Biloptin supplier is an individual or a company that provides Solu Biloptin active pharmaceutical ingredient (API) or Solu Biloptin finished formulations upon request. The Solu Biloptin suppliers may include Solu Biloptin API manufacturers, exporters, distributors and traders.
click here to find a list of Solu Biloptin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Solu Biloptin DMF (Drug Master File) is a document detailing the whole manufacturing process of Solu Biloptin active pharmaceutical ingredient (API) in detail. Different forms of Solu Biloptin DMFs exist exist since differing nations have different regulations, such as Solu Biloptin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Solu Biloptin DMF submitted to regulatory agencies in the US is known as a USDMF. Solu Biloptin USDMF includes data on Solu Biloptin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Solu Biloptin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Solu Biloptin suppliers with USDMF on PharmaCompass.
Solu Biloptin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Solu Biloptin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Solu Biloptin GMP manufacturer or Solu Biloptin GMP API supplier for your needs.
A Solu Biloptin CoA (Certificate of Analysis) is a formal document that attests to Solu Biloptin's compliance with Solu Biloptin specifications and serves as a tool for batch-level quality control.
Solu Biloptin CoA mostly includes findings from lab analyses of a specific batch. For each Solu Biloptin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Solu Biloptin may be tested according to a variety of international standards, such as European Pharmacopoeia (Solu Biloptin EP), Solu Biloptin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Solu Biloptin USP).